Reduced dose azacitidine plus venetoclax as maintenance therapy in acute myeloid leukaemia following intensive or low-intensity induction: a single-centre, single-arm, phase 2 trial

Alexandre Bazinet, Hagop M. Kantarjian, Álex Bataller, Naveen Pemmaraju, Gautam Borthakur, Kelly S. Chien, Yesid Alvarado, Prithviraj Bose, Elias Jabbour, Musa Yılmaz, Courtney D. DiNardo, Ghayas C. Issa, Guillermo Montalban‐Bravo, Nicholas J. Short, Koji Sasaki, Debra Bull-Linderman, Naval Daver, Guillermo Garcia‐Manero, Farhad Ravandi, Tapan M. Kadia